금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Global Diesel Crunch Worsens Ahead of Peak Winter Demand
As peace in the Persian Gulf remains elusive and Ukrainian drones keep raining on Russian refineries...
Why Kevin Warsh Might Raise Interest Rates at the Next FOMC Meeting, Despite a Weak Jobs Report
Fed chair Kevin Warsh is focused on getting inflation to 2%....
GraniteShares YieldBOOST MARA ETF declares $0.1036 dividend
Tandem forecasts $265M Q3 sales while advancing Mobi tubeless scaled launch in H2 2026
GraniteShares YieldBOOST RIOT ETF declares $0.1755 dividend
Dollar drops, stocks climb as weak US jobs data eases rate fears
The dollar fell sharply Friday after the US economy shed thousands of jobs in July, an economic blow that lowered the risk of an interest rate hike by the Federal Reserve that could slow growth in the ...
History Says This Is the Single Best Strategy for Investors if a Market Crash Is Imminent
This group of stocks tends to hold up well in downturns and keep up with the market during upswings.
SandRidge Q2 Earnings Rise Y/Y on Higher Production & Oil Prices
SD Q2 earnings climb y/y as revenues jump 48%, driven by higher production, stronger oil prices and Cherokee drilling.
Hamilton Beach Q2 Earnings Surge Y/Y on Tariff Refunds, Sales Rise
HBB's Q2 revenues rise 11.6% y/y as tariff refunds boost earnings and margins, prompting an improved 2026 profit outlook.
Tech Stocks Shake Off Another Memory Stock Slide
Three of its top holdings, flash memory/data storage companies Seagate, Western Digital, and Sandisk, were among the biggest losers in the S&P 500 Friday. The stocks continued to slide following West ...
Urban One Q2 Loss Narrows Y/Y, Adjusted EBITDA Outlook Cut
UONE's Q2 loss narrows as revenues fall 6.4% y/y and impairment charges decline. Management cuts its 2026 adjusted EBITDA forecast.
Meet the Low-Cost Vanguard ETF That Just Gained 11% Over 4 Days, Thanks to a Combined 33% Weighting in Nvidia, Microsoft, Micron, and Broadcom. Here's Why It's Still a Top Buy Now.
The tech sector is chock-full of companies with high-quality earnings growth.
What Insmed Stock's Premium Is Actually Buying
Management has just raised the peak-sales estimate, and a large slice of it belongs to a drug still running Phase III trials.
Doximity’s stock skyrockets 50% on medical AI excitement. Can the rally last?
While one analyst thinks Doximity has a compelling AI opportunity, another worries that the company could cannibalize its core business of medical networking.